From: Long non-coding RNAs affecting cell metabolism in cancer
lncRNAs | Expres-sion | Cell localization | Function | Target/pathways (interactors) | Mechanism of actions | References |
---|---|---|---|---|---|---|
lncRNAs affecting GLUCOSE metabolism | ||||||
BCAR4 | Up | Nucleus | Oncogenic | Hippo pathway | Coordinates the Hedgehog signaling to enhance the transcription of glycolysis activators HK2 and PFKFB3 | [99] |
FGF13-AS1 | Down | Cytoplasm | Tumor suppressor | IGF2BPs and Myc | Reduce the half-life of c-Myc (Myc) mRNA by binding IGF2BPs and disrupting the interaction between them | [141] |
H19 | Up | Cytoplasm | Oncogenic | Pyruvate dehydro genase kinase 1 (PDK1) | Acts as a competitive endogenous RNA for miRNA let-7 to release Hypoxia-inducible factor 1α, leading to an increase in PDK1 expression | [71] |
lincRNA-p21 | Up | Cytoplasm | Oncogenic | HIF-1a | Inhibits the degradation of HIF-1α; activates GLUT1 and LDHA; promotes Warburg effect | [142] |
LINK-A | Up | Cytoplasm | Oncogenic | HIF-1a | Prevents the degradation of HIF-1α; recruites LRRK2 to phosphorylate HIF-1α, which promotes Warburg effect | [100] |
YIYA | Up | Cytoplasm | Oncogenic | PFKFB3 | Promotes catalysis of glucose 6-phosphate to fructose-2,6-bisphosphate/fructose-1,6-bisphosphate via CDK6 phosphorylation | [105] |
MEG3 | Down | Cytoplasm | Tumor suppressor | PI3K/Akt/miR-21, HK2 | Inactivates the PI3K/Akt pathway functioning as a ceRNA of miR-21 | [88] |
UCA1 | Up | Nucleus | Oncogenic | HK2 | Directs cell metabolism towards aerobic glycolysis through AKT and STAT3 activation | [143] |
SNHG5 | Up | Cytoplasm | Oncogenic | miR-299 | Promotes the glycolysis of breast cancer cell through regulating BACH1 via targeting miR‑299 | [144] |
FGD5-AS1 | Up | Cytoplasm | Oncogenic | miR-195-5p | Mediates breast cancer glycolysis by upregulating NUAK2 via sponging miR‑195‑5p | [145] |
GHET1 | Up | Oncogenic | HIF-1a and LATS1 | Stabilizes the activity of the Hippo/YAP signaling pathway | [146] | |
HIFAL | Up | Cytoplasm | Oncogenic | hnRNPF | Induce translocation of PKM2/PHD3 complex to enhance HIF-1α transactivation | [132] |
MIR210HG | Up | Cytoplasm | Oncogenic | HIF-1a | Potentiates HIF-1a translation via directly binding to its mRNA 5’-UTR | [57] |
MAFG-AS1 | Up | Cytoplasm | Oncogenic | miR-3196 | Through the axis miR-3196/TFAP2A, MAFG-AS1 activates the JAK2/STAT3 signaling pathway | [147] |
LINC00346 | Up | Cytoplasm | Oncogenic | miR-148a/b | Increases breast cancer cell glycolysis by down-regulating miR-148a/b and inducing GLUT1 expression | [148] |
lncRNAs affecting LIPID metabolism | ||||||
NEAT1 | Up | Cytoplasm | Oncogenic | miR-124 | NEAT1 and STAT3 form a feedback loop via sponging miR-124 to promote BC progression | [118] |
SRA | Up | [138] | ||||
LINK-A | Up | Oncogenic | AKT and PIP3 | Facilitates AKT recruitment to PIP3 and enzymatic activation of AKT | [100] | |
Mitochondrial lncRNA | ||||||
MTORT1 | Down | Mitochondria | Tumor suppressor | miR- 26a-5p | Serves as sponge of miR-26a-5p to up-regulate its target genes, CREB1 and STK4 | [139] |
GAS5 | Down | Mitochondria | Tumor suppressor | MDH2 and SIRT3 | Modulates mitochondrial tricarboxylic acid flux by disrupting metabolic enzyme tandem association of fumarate hydratase, malate dehydrogenase and citrate synthase | [101] |